查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球血管造影導管市場 - 2023-2030年
市場調查報告書
商品編碼
1290362

全球血管造影導管市場 - 2023-2030年

Global Angiographic Catheters Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

全球血管造影導管市場在2022年達到12.573億美元，預計到2030年將見證有利可圖的成長，達到22.298億美元。在預測期內（2023-2030年），全球血管造影導管市場預計將呈現7.6%的複合成長率。醫療設備的快速技術進步，以及政府對醫療基礎設施建設的支出增加，是推動全球血管造影導管市場的重要因素。

血管造影導管在介入心臟病學和放射學領域極為重要。這些導管是專門的醫療設備，用於觀察血管並進行診斷和治療。

市場動態

心血管疾病的發病率不斷增加

心血管疾病的發病率不斷上升，如冠狀動脈疾病、周圍動脈疾病和心臟病發作，促使對診斷和介入程序的需求不斷增加。血管造影導管是進行血管造影的重要工具，可以觀察和評估血管，有助於這些疾病的診斷和治療。

同時，技術的進步也推動了血管造影市場的發展，使其性能和安全性得到提高。諸如改進的成像能力、更好的導管材料和增強的可操作性等創新，使手術更加精確和微創，促使這些導管的採用和需求增加。

嚴格的監管要求

血管造影導管市場需要接受嚴格的監管，並符合各種醫療設備的規定。滿足這些要求會增加與產品開發和批准相關的時間和成本。

保險公司的報銷政策和覆蓋範圍會影響血管造影導管的採用。如果報銷率低，或者某些涉及血管造影導管的手術不在保險範圍內，醫療機構和供應商可能不願意投資於這些設備或進行這些手術。

COVID-19影響分析

血管造影導管市場通過各種因素受到COVID-19的巨大影響，如手術量減少。在大流行期間，許多醫院和醫療機構經歷了選擇性手術的大幅減少，包括非緊急的血管造影手術。這種手術量的下降直接影響了對血管造影導管的需求。

由於醫療系統的壓力和優先考慮資源的需要，出現了一個轉變，即主要為緊急或緊急病例進行血管造影手術。這一轉變降低了血管造影導管的總體利用率。

大流行病造成的全球供應鏈中斷促使了包括血管造影導管在內的醫療設備的生產、分銷和供應方面的挑戰。生產設施面臨臨時關閉、運輸限制和原料短缺，促使延誤和供應鏈中斷。

目錄

第一章：方法和範圍

  • 研究方法
  • 報告的研究目標和範圍

第二章：定義和概述

第三章：執行摘要

  • 按產品類型分類的摘要
  • 按應用分類的摘要
  • 按終端用戶分類

第四章：動態變化

  • 影響因素
    • 驅動因素
      • 心血管疾病的發病率不斷上升
    • 限制因素
      • 嚴格的監管要求
    • 機會
      • 研究與開發活動的成長
    • 影響分析

第五章：行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價格分析
  • 監管分析

第六章：COVID-19分析

  • COVID-19的分析
    • COVID-19之前的情況
    • COVID-19期間的情況
    • COVID-19之後的情況
  • 在COVID-19期間的定價動態
  • 需求-供應譜系
  • 大流行期間與市場有關的政府計劃
  • 製造商的戰略計劃
  • 結語

第七章：按產品類型

  • 縮管球囊導管
  • 常規導管
  • 切割球囊導管
  • 藥物洗脫型球囊導管

第八章：按應用分類

  • 血管內
  • 冠狀動脈
  • 神經科
  • 腫瘤學
  • 其他

第九章：按終端用戶分類

  • 醫院
  • 專業診所
  • 非住院手術中心
  • 其他

第十章：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 亞太其他地區
  • 中東和非洲

第11章：競爭格局

  • 競爭格局
  • 市場定位/佔有率分析
  • 合併和收購分析

第十二章：公司簡介

  • Medtronic
      • 公司概述
      • 產品組合和描述
      • 財務概況
      • 主要發展情況
  • 波士頓科學公司
  • 泰爾茂醫療公司
  • 卡迪納爾健康公司
  • Merit Medical Systems, Inc.
  • 阿博特
  • 亞琛共振公司（Aachen Resonance Entwicklungsgesellschaft Mbh
  • ZOLL醫療公司
  • Contego Medical, Inc
  • Asahi Intecc Co.Ltd.）。

第十三章：附錄

簡介目錄
Product Code: MD1318

Market Overview

The Global Angiographic Catheters Market reached US$ 1,257.3 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 2,229.8 million by 2030. The global angiographic catheters market is expected to exhibit a CAGR of 7.6% during the forecast period (2023-2030). Rapid technical advancements in medical equipment, as well as rising government expenditures for the construction of healthcare infrastructure, are important factors driving the global angiographic catheters market.

Angiographic catheters are extremely important in the fields of interventional cardiology and radiology. These catheters are specialized medical devices that are used to see blood vessels and perform diagnostic and therapeutic treatments.

Market Dynamics

Increasing Prevalence of Cardiovascular Diseases

The rising incidence of cardiovascular conditions such as coronary artery disease, peripheral artery disease, and heart attacks has led to a growing need for diagnostic and interventional procedures. Angiographic catheters are essential tools in performing angiography to visualize and assess blood vessels, aiding in the diagnosis and treatment of these diseases.

Also, technological advancements drive the angiographic market in such a way that it has improved their performance and safety. Innovations such as improved imaging capabilities, better catheter materials, and enhanced maneuverability have made procedures more accurate and minimally invasive, leading to increased adoption and demand for these catheters.

Stringent Regulatory Requirements

The angiographic catheter market is subject to strict regulatory oversight and compliance with various medical device regulations. Meeting these requirements can increase the time and cost associated with product development and approval.

Reimbursement policies and coverage by insurance providers can impact the adoption of angiographic catheters. If reimbursement rates are low or if certain procedures involving angiographic catheters are not covered, healthcare facilities and providers may be reluctant to invest in these devices or perform the procedures.

COVID-19 Impact Analysis

The angiographic catheters market was hugely affected by COVID-19 through various factors like decreased procedure volumes. During the pandemic, many hospitals and healthcare facilities experienced a significant reduction in elective procedures, including non-emergency angiographic procedures. This decline in procedure volumes directly affected the demand for angiographic catheters.

Due to the strain on healthcare systems and the need to prioritize resources, there was a shift towards performing angiographic procedures primarily for urgent or emergency cases. This shift reduced the overall utilization of angiographic catheters.

The global supply chain disruptions caused by the pandemic resulted in challenges in the production, distribution, and availability of medical devices, including angiographic catheters. Manufacturing facilities faced temporary closures, transportation restrictions, and shortages of raw materials, leading to delays and supply chain interruptions.

Segment Analysis

The global angiographic catheters market is segmented based on product type, application and end user.

The Scoring Balloon Catheters in Product Segment will be Dominated by Market Players During the Forecast Period

The scoring balloon catheters segment is expected to hold a substantial share of around 37.2% in the angiography catheter market. Where scoring balloon catheters are used during certain interventional procedures, both scoring balloon catheters and angiography catheters may be used in sequence. For example, during an angioplasty procedure, an angiography catheter is first used to obtain diagnostic images of the affected blood vessels. Once the lesion has been identified, a scoring balloon catheter may be introduced to facilitate lesion modification and optimize vessel dilation.

Geographical Analysis

North America is the Dominating Region Accounting for 41.7% During the Forecast Period

North America is the dominating region for the angiographic catheters market due to well-developed healthcare infrastructure and a high level of healthcare spending, which further supports the market growth. Technological advancements in angiographic catheters, such as the development of new materials, improved designs, and enhanced imaging capabilities, also contribute to market expansion.

Factors that influence the market for angiographic catheters include the prevalence of cardiovascular diseases, advancements in technology, healthcare infrastructure, and reimbursement policies. North America, particularly the United States, has a significant burden of cardiovascular diseases, which drives the demand for angiographic catheters.

Competitive Landscape

The major global players include: Medtronic, Boston Scientific Corporation, Terumo Medical Corporation, Cardinal Health, Merit Medical Systems, Inc, Abbott, Aachen Resonance Entwicklungsgesellschaft Mbh, Zoll Medical Corporation, Contego Medical, Inc, and Asahi Intecc Co. LTD.

Why Purchase the Report?

  • To visualize the global angiographic catheters market segmentation based on the treatment, application, end user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global angiographic catheters market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global angiographic catheters market report would provide approximately 92 tables, 108 figures and 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing prevalence of cardiovascular diseases
    • 4.1.2. Restraints
      • 4.1.2.1. Stringent Regulatory Requirements
    • 4.1.3. Opportunity
      • 4.1.3.1. Growth in R & D activities
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1 Scoring Balloon Catheters
  • 7.2 Conventional Catheters
  • 7.3 Cutting Balloon Catheters
  • 7.4 Drug-Eluting Balloon Catheters

8. By Application

  • 8.1. Endovascular
  • 8.2. Coronary
  • 8.3. Neurology
  • 8.4. Oncology
  • 8.5. Others

9. By End User

  • 9.1. Hospitals
  • 9.2. Specialty Clinics
  • 9.3. Ambulatory Surgical Centers
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Medtronic
      • 12.1.1.1. Company Overview
      • 12.1.1.2. Product Portfolio and Description
      • 12.1.1.3. Financial Overview
      • 12.1.1.4. Key Developments
  • 12.2. Boston Scientific Corporation
  • 12.3. Terumo Medical Corporation
  • 12.4. Cardinal Health
  • 12.5. Merit Medical Systems, Inc.
  • 12.6. Abbott
  • 12.7. Aachen Resonance Entwicklungsgesellschaft Mbh
  • 12.8. ZOLL Medical Corporation
  • 12.9. Contego Medical, Inc
  • 12.10. Asahi Intecc Co. Ltd.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us